Bharat Immunologicals & Biologicals Corporation Limited (BOM:524663)
India flag India · Delayed Price · Currency is INR
22.70
-0.21 (-0.92%)
At close: May 2, 2025

BOM:524663 Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2014 - 2018
Period Ending
May '25 Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 2014 - 2018
Market Capitalization
9809581,2131,965251332
Upgrade
Market Cap Growth
-5.98%-21.03%-38.24%681.79%-24.32%-60.96%
Upgrade
Enterprise Value
-1,6781,9022,321533149
Upgrade
Last Close Price
22.7022.1928.1045.505.827.69
Upgrade
PS Ratio
12.812.151.552.300.380.40
Upgrade
PB Ratio
1.251.091.155.771.231.08
Upgrade
P/TBV Ratio
1.251.091.155.771.231.08
Upgrade
P/FCF Ratio
-8.80-16.680.74-
Upgrade
P/OCF Ratio
-8.80-16.680.74-
Upgrade
EV/Sales Ratio
-3.762.432.720.800.18
Upgrade
EV/FCF Ratio
-15.41-19.701.56-
Upgrade
Debt / Equity Ratio
0.950.800.740.800.151.05
Upgrade
Debt / FCF Ratio
-6.45-2.320.09-
Upgrade
Asset Turnover
0.040.220.500.740.530.94
Upgrade
Inventory Turnover
1.402.082.412.501.708.75
Upgrade
Quick Ratio
0.190.200.090.070.200.86
Upgrade
Current Ratio
0.330.380.650.530.921.12
Upgrade
Return on Equity (ROE)
-21.00%-17.19%-12.56%-66.45%-39.93%-16.99%
Upgrade
Return on Assets (ROA)
-6.28%-5.00%-2.04%-11.41%-5.21%-6.56%
Upgrade
Return on Capital (ROIC)
-7.58%-5.87%-2.64%-31.05%-15.17%-11.65%
Upgrade
Earnings Yield
-18.86%-17.36%-7.21%-9.22%-40.63%-17.45%
Upgrade
FCF Yield
-11.37%-34.71%5.99%135.61%-96.73%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.